Hematopoietic cell transplantation in inborn errors of immunity Part I: severe combined immunodeficiency
DOI:
https://doi.org/10.46765/2675-374X.2025v6n1e299Keywords:
Hematopoietic Stem Cell Transplantation, Severe Combined Immunodeficiency, Primary Immunodeficiency DiseasesAbstract
Severe Combined Immunodeficiencies (SCID) are rare diseases characterized by a blockage in T-lymphocyte development. Hematopoietic Cell Transplantation (HCT) is the primary curative therapy, with the highest survival rates correlated to early diagnosis and the absence of active infections at transplant. The gold standard is a matched related sibling donor (MSD), but alternative donors like haploidentical family donors are increasingly used. Conditioning regimens vary, with reduced intensity busulfan and fludarabine often indicated. Early diagnosis via newborn screening and referral to experienced HCT centers are crucial for improving outcomes. Long-term follow-up is essential, as the cumulative incidence of late effects, such as neurologic and neurodevelopmental issues, increases over time.
References
1. Dvorak CC, Haddad E, Heimall J, Dunn E, Buckley RH, Kohn DB, Cowan MJ, Pai SY, Griffith LM, Cuvelier GDE, Eissa H, Shah AJ, O’Reilly RJ, Pulsipher MA, Wright NAM, Abraham RS, Satter LF, Notarangelo LD, Puck JM. The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 Definitions. J Allergy Clin Immunol. 2023;151(2):539–46. https://doi.org/10.1016/j.jaci.2022.10.022 DOI: https://doi.org/10.1016/j.jaci.2022.10.022
2. Collins C, Sharpe E, Silber A, Kulke S, Hsieh EWY. Congenital athymia: genetic etiologies, clinical manifestations, diagnosis, and treatment. J Clin Immunol. 2021;41(5):881–95. https://doi.org/10.1007/s10875-021-01059-7 DOI: https://doi.org/10.1007/s10875-021-01059-7
3. Dorsey MJ, Wright NAM, Chaimowitz NS, Dávila Saldaña BJ, Miller H, Keller MD, Thakar MS, Shah AJ, Abu-Arja R, Andolina J, Aquino V, Barnum JL, Bednarski JJ, Bhatia M, Bonilla FA, Butte MJ, Bunin NJ, Chandra S, Chaudhury S, Chen K, Chong H, Cuvelier GDE, Dalal J, DeFelice ML, DeSantes KB, Forbes LR, Gillio A, Goldman F, Joshi AY, Kapoor N, Knutsen AP, Kobrynski L, Lieberman JA, Leiding JW, Oshrine B, Patel KP, Prockop S, Quigg TC, Quinones R, Schultz KR, Seroogy C, Shyr D, Siegel S, Smith AR, Torgerson TR, Vander Lugt MT, Yu LC, Cowan MJ, Buckley RH, Dvorak CC, Griffith LM, Haddad E, Kohn DB, Logan B, Notarangelo LD, Pai SY, Puck J, Pulsipher MA, Heimall J. Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers. J Clin Immunol. 2021;41(1):38–50. https://doi.org/10.1007/s10875-020-00865-9 DOI: https://doi.org/10.1007/s10875-020-00865-9
4. Mazzucchelli JT, Bonfim C, Castro GG, Condino-Neto AA, Costa NM, Cunha L, Dantas EO, Dantas VM, de Moraes-Pinto MI, Fernandes JF, Goes HC, Goudouris E, Grumach AS, Guirau LM, Kuntze G, Mallozzi MC, Monteiro FP, Moraes LS, Nudelman V, Pinto JA, Rizzo MC, Porto-Neto AC, Roxo-Junior P, Ruiz M, Rullo VE, Seber A, Takano OA, Tavares FS, Toledo E, Vilela MM, Costa-Carvalho BT. Severe combined immunodeficiency in Brazil: management, prognosis, and BCG-associated complications. J Investig Allergol Clin Immunol.2014;24(3):184–91.
5. Haddad E, Hoenig M. Hematopoietic stem cell transplantation for severe combined immunodeficiency (SCID). Front Pediatr. 2019;7:481. https://doi.org/10.3389/fped.2019.00481 DOI: https://doi.org/10.3389/fped.2019.00481
6. Fernandes JF, Rocha V, Labopin M, Neven B, Moshous D, Gennery AR, Friedrich W, Porta F, Diaz de Heredia C, Wall D, Bertrand Y, Veys P, Slatter M, Schulz A, Chan KW, Grimley M, Ayas M, Gungor T, Ebell W, Bonfim C, Kalwak K, Taupin P, Blanche S, Gaspar HB, Landais P, Fischer A, Gluckman E, Cavazzana-Calvo M; Eurocord and Inborn Errors Working Party of European Group for Blood and Marrow Transplantation. Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood? Blood. 2012;119(12):2949–55. https://doi.org/10.1182/blood-2011-06-363572 DOI: https://doi.org/10.1182/blood-2011-06-363572
7. Lum SH, Albert MH, Gilbert P, Sirait T, Algeri M, Muratori R, Fournier B, Laberko A, Karakukcu M, Unal E, Ayas M, Yadav SP, Fisgin T, Elfeky R, Fernandes J, Faraci M, Cole T, Schulz A, Meisel R, Zecca M, Ifversen M, Biffi A, Diana JS, Vallée T, Giardino S, Ersoy GZ, Moshous D, Gennery AR, Balashov D, Bonfim C, Locatelli F, Lankester A, Neven B, Slatter M. Outcomes of HLA-mismatched HCT with TCRαβ/CD19 depletion or post-HCT cyclophosphamide for inborn errors of immunity. Blood. 2024;144(5):565–80. https://doi.org/10.1182/blood.2024024038 DOI: https://doi.org/10.1182/blood.2024024038
8. The 48th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians - Oral Sessions (O009-O155). Bone Marrow Transplant. 2022;57(Suppl. 1):16–99. https://doi.org/10.1038/s41409-022-01815-2 DOI: https://doi.org/10.1038/s41409-022-01815-2
9. Richardson PG, Riches ML, Kernan NA, Brochstein JA, Mineishi S, Termuhlen AM, Arai S, Grupp SA, Guinan EC, Martin PL, Steinbach G, Krishnan A, Nemecek ER, Giralt S, Rodriguez T, Duerst R, Doyle J, Antin JH, Smith A, Lehmann L, Champlin R, Gillio A, Bajwa R, D’Agostino RB Sr, Massaro J, Warren D, Miloslavsky M, Hume RL, Iacobelli M, Nejadnik B, Hannah AL, Soiffer RJ. Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure. Blood. 2016;127(13):1656–65. https://doi.org/10.1182/blood-2015-10-676924 DOI: https://doi.org/10.1182/blood-2015-10-676924
10. Lankester AC, Albert MH, Booth C, Gennery AR, Güngör T, Hönig M, Morris EC, Moshous D, Neven B, Schulz A, Slatter M, Veys P; Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation and the European Society for Immune Deficiencies, and European Reference Network on Rare Primary Immunodeficiency Autoinflammatory Autoimmune diseases (RITA). EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity. Bone Marrow Transplant. 2021;56(9):2052–62. https://doi.org/10.1038/s41409-021-01378-8 DOI: https://doi.org/10.1038/s41409-021-01378-8
11. Lankester AC, Neven B, Mahlaoui N, von Asmuth EGJ, Courteille V, Alligon M, Albert MH, Serra IB, Bader P, Balashov D, Beier R, Bertrand Y, Blanche S, Bordon V, Bredius RG, Cant A, Cavazzana M, Diaz-de-Heredia C, Dogu F, Ehlert K, Entz-Werle N, Fasth A, Ferrua F, Ferster A, Formankova R, Friedrich W, Gonzalez-Vicent M, Gozdzik J, Güngör T, Hoenig M, Ikinciogullari A, Kalwak K, Kansoy S, Kupesiz A, Lanfranchi A, Lindemans CA, Meisel R, Michel G, Miranda NAA, Moraleda J, Moshous D, Pichler H, Rao K, Sedlacek P, Slatter M, Soncini E, Speckmann C, Sundin M, Toren A, Vettenranta K, Worth A, Yeşilipek MA, Zecca M, Porta F, Schulz A, Veys P, Fischer A, Gennery AR. Hematopoietic cell transplantation in severe combined immunodeficiency: The SCETIDE 2006-2014 European cohort. J Allergy Clin Immunol. 2022;149(5): 1744–54.e8. https://doi.org/10.1016/j.jaci.2021.10.017 DOI: https://doi.org/10.1016/j.jaci.2021.10.017
12. Petit A, Neven B, Min V, Mahlaoui N, Moshous D, Castelle M, Allouche M, Stérin A, Visentin S, Saultier P, Boucekine M, Shawket AM, Picard C, Auquier P, Michel G, Fischer A, Barlogis V. Impact of graft function on health status and quality of life in very long-term survivors who received an HSCT for inborn errors of immunity, a prospective study of the CEREDIH. Transplant Cell Ther. 2023;29(9):582.e1–e6. https://doi.org/10.1016/j.jtct.2023.06.006 DOI: https://doi.org/10.1016/j.jtct.2023.06.006
13. Riller Q, Fourgeaud J, Bruneau J, De Ravin SS, Smith G, Fusaro M, Meriem S, Magerus A, Luka M, Abdessalem G, Lhermitte L, Jamet A, Six E, Magnani A, Castelle M, Lévy R, Lecuit MM, Fournier B, Winter S, Semeraro M, Pinto G, Abid H, Mahlaoui N, Cheikh N, Florkin B, Frange P, Jeziorski E, Suarez F, Sarrot Reynauld F, Nouar D, Debray D, Lacaille F, Picard C, Pérot P, Regnault B, Da Rocha N, de Cevins C, Delage L, Pérot BP, Vinit A, Carbone F, Brunaud C, Marchais M, Stolzenberg MC, Asnafi V, Molina T, Rieux-Laucat F, Notarangelo LD, Pittaluga S, Jais JP, Moshous D, Blanche S, Malech H, Eloit M, Cavazzana M, Fischer A, Ménager MM, Neven B. Late-onset enteric virus infection associated with hepatitis (EVAH) in transplanted SCID patients. J Allergy Clin Immunol. 2023;151(6):1634–45. https://doi.org/10.1016/j.jaci.2022.12.822 DOI: https://doi.org/10.1016/j.jaci.2022.12.822
14. Aranda CS, Pimentel MG, Guimaraes RR, Fernandes JF, Rizzo MCFV, Ishizuka E, de Oliveira Junior EB, Hadachi SM, Hayashi GY, de Andrade CEF, de Marco Mauro AM, Sole D, Condino-Neto A. Newborn screening for inborn errors of immunity in Brazil. Pediatr Allergy Immunol. 2025;36(2):e70047. https://doi.org/10.1111/pai.70047 DOI: https://doi.org/10.1111/pai.70047
15. Kohn DB, Hershfield MS, Puck JM, Aiuti A, Blincoe A, Gaspar HB, Notarangelo LD, Grunebaum E. Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency. J Allergy Clin Immunol. 2019;143(3):852–63. https://doi.org/10.1016/j.jaci.2018.08.024 DOI: https://doi.org/10.1016/j.jaci.2018.08.024
16. Eissa H, Thakar MS, Shah AJ, Logan BR, Griffith LM, Dong H, Parrott RE, O’Reilly RJ, Dara J, Kapoor N, Forbes Satter L, Chandra S, Kapadia M, Chandrakasan S, Knutsen A, Jyonouchi SC, Molinari L, Rayes A, Ebens CL, Teira P, Dávila Saldaña BJ, Burroughs LM, Chaudhury S, Chellapandian D, Gillio AP, Goldman F, Malech HL, DeSantes K, Cuvelier GDE, Rozmus J, Quinones R, Yu LC, Broglie L, Aquino V, Shereck E, Moore TB, Vander Lugt MT, Mousallem TI, Oved JH, Dorsey M, Abdel-Azim H, Martinez C, Bleesing JH, Prockop S, Kohn DB, Bednarski JJ, Leiding J, Marsh RA, Torgerson T, Notarangelo LD, Pai SY, Pulsipher MA, Puck JM, Dvorak CC, Haddad E, Buckley RH, Cowan MJ, Heimall J. Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study. J Allergy Clin Immunol. 2024;153(1):287–96. https://doi.org/10.1016/j.jaci.2023.09.027 DOI: https://doi.org/10.1016/j.jaci.2023.09.027
17. Hardin O, Lokhnygina Y, Buckley RH. Long-term clinical outcomes of severe combined immunodeficiency patients given nonablative marrow transplants. J Allergy Clin Immunol Pract. 2022;10(4):1077–83. https://doi.org/10.1016/j.jaip.2021.11.032 DOI: https://doi.org/10.1016/j.jaip.2021.11.032
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Rafaella Muratori, Juliana Folloni Fernandes, Gisele Loth, Ana Karine Vieira, Paulo Klinger, Simone Franco, Carmem Bonfim
This work is licensed under a Creative Commons Attribution 4.0 International License.
